Non-profit generic drug maker formed by hospital systems to secure supply of essential injectables, including oncology drugs.
Civica Rx, a nonprofit based in Lehi, Utah, is a generic drug maker formed by hospital systems to secure the supply of essential injectables, including oncology drugs. It contracts for and manufactures shortage-prone sterile injectables and operates a plant in Petersburg, Virginia. OnCo links it to generic oncology drug supply and shortage mitigation and to the idea of a non-profit manufacturer for shortage-prone generic chemotherapy. Whether a nonprofit can hold prices and supply steady through the recurring shortages of injectable chemotherapy is the question it was created to answer. The drug shortage technology page carries the wider picture.
Shares Generic oncology drug supply and shortage mitigation, Generic sterile injectables (the 2023 platinum shortage) and the tag supporting.
Shares Generic oncology drug supply and shortage mitigation, Generic sterile injectables (the 2023 platinum shortage) and the tag supporting.
Shares Generic oncology drug supply and shortage mitigation, Generic sterile injectables (the 2023 platinum shortage).
Shares Generic oncology drug supply and shortage mitigation, Generic sterile injectables (the 2023 platinum shortage).
Shares Generic oncology drug supply and shortage mitigation, Generic sterile injectables (the 2023 platinum shortage).
Shares Generic oncology drug supply and shortage mitigation, Generic sterile injectables (the 2023 platinum shortage).